AOD 9604 is a peptide originally derived from a small, targeted portion of human growth hormone
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
A common dose is 1000 mcg daily, given either intramuscularly (IM) or subcutaneously
How to give yourself a subcutaneous injection Gather your supplies Place your supplies on a clean, flat surface (such as a table or countertop)
Therefore, it is crucial to inform your healthcare provider of all medications, supplements, and vitamins that you are taking before starting this medication
promotes fat oxidation Route Subcutaneous injection Acts on appetite